×
About 10,888 results

Do You Really Know Your Patient? It's a Key to Advancing Health Equity
https://www.medscape.com/viewarticle/983950

Nov 15th, 2022 - If clinical care — both access to care and its quality — account for 20% of an individual's health, why have the Centers for Medicare and Medicaid (CMS) assigned the responsibility to hospitals and clinicians of collecting social determinants of health (SDOH) data? Why is the burden laid on healthcare when the highest attributable cause of an individual's health comes from social and economic f...

Peanut-Allergic Toddlers Also Benefit From Oral Immunotherapy With Palforzia
https://www.medscape.com/viewarticle/984053

Nov 14th, 2022 - LOUISVILLE, Kentucky — Compared with placebo, treatment with peanut (Arachis hypogaea) allergen powder-dnfp (Palforzia) significantly improved the amount of peanut protein that could be tolerated by peanut-allergic children between 1-3 years of age after 12 months of treatment with the oral immunotherapy, according to results of a randomized clinical trial. The phase 3 POSEIDON study also showe...

Monkeypox Features Include Mucocutaneous Involvement in Almost All Cases
https://www.medscape.com/viewarticle/981834

Oct 4th, 2022 - MILAN – In the current spread of monkeypox among countries outside of Africa, this zoonotic orthopox DNA virus is sexually transmitted in more than 90% of cases, mostly among men having sex with men (MSM), and can produce severe skin and systemic symptoms but is rarely fatal, according to a breaking news presentation at the annual congress of the European Academy of Dermatology and Venereology....

Probiotics Improve Physical Function in COPD
https://www.medscape.com/viewarticle/976514

Jul 1st, 2022 - Probiotics improve strength and functional capacity in patients with COPD, based on a randomized, placebo-controlled trial. The improvements stem from decreased gut permeability, which reduces circulating inflammatory cytokines, leading to stabilization of neuromuscular junctions, reported lead author Asima Karim, MBBS, PhD, of the University of Sharjah, United Arab Emirates, and colleagues. "T...

CDC Says About 20% Get Long COVID. New Models Try to Define It
https://www.medscape.com/viewarticle/974905

Jun 1st, 2022 - As the number of people reporting persistent, and sometimes debilitating, symptoms from COVID-19 increases, researchers have struggled to pinpoint exactly how common so-called "long COVID" is, as well as how to clearly define exactly who has it or who is likely to get it. Now, Centers for Disease Control and Prevention (CDC) researchers have concluded that 1 in 5 adults aged 18 and older have a...

Long-term Efficacy, Safety Data for Ixekizumab in Pediatric Psoriasis Reported
https://www.medscape.com/viewarticle/972678

Apr 25th, 2022 - Two-year follow-up data from an international, multicenter, randomized trial of ixekizumab in pediatric patients with moderate to severe psoriasis demonstrate prolonged efficacy and no new safety signals with the interleukin (IL)-17 inhibitor, investigators reported. In addition, findings of a substudy, which evaluated randomized withdrawal of treatment after 60 weeks, suggest patients were abl...

Alcoholic Hepatitis Admissions of Young Adults Spike in Pandemic
https://www.medscape.com/viewarticle/962918

Nov 15th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. In the first year of the COVID-19 pandemic, hospital admissions for alcoholic hepatitis (AH) among adults aged 40 years and younger doubled in Boston's largest hospital system compared with the average of the prior 4 prepandemic years, according to a new study. Beginning March 2020, hospitals in...

SCM21: Pandemic Forces Another Virtual Kidney Meeting
https://www.medscape.com/viewarticle/948532

Apr 1st, 2021 - The ongoing spectre of the COVID-19 pandemic looms large and central in the minds of those planning the 2021 National Kidney Foundation's Spring Clinical Meetings (NKF SCM21). The conference, which runs April 6-10, will feature the latest perspectives on the effects of COVID-19 on the kidneys. The sessions "include a focus on health disparities with COVID-19, and acute kidney disease and manage...

How Has COVID-19 Impacted Tribal Populations?
https://www.medscape.com/viewarticle/948362

Mar 30th, 2021 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. JOHN WHYTE: Welcome, everyone. I'm Dr. John Whyte, Chief Medical Officer at WebMD. And you're watching Coronavirus in Context. For the last few months, we've been talking about the impact of coronavirus on vulnerable populations. But honestly, one population that we've overlooked are tribal populations. So tod...

Cancer News to 'Shout From the Rooftops'
https://www.medscape.com/viewarticle/946792

Mar 16th, 2021 - This transcript has been edited for clarity. I'm David Kerr, professor of cancer medicine at the University of Oxford. I'd like to discuss a paper published recently in Annals of Oncology by some pals of mine, Carlo La Vecchia, Paolo Boffetta, and their colleagues — a fantastic bunch of Italian epidemiologists predominantly from the Milan region. They've done some wonderful work over decades to...

A Patient Insisted on a Trial. Docs Listened and Saved Lives
https://www.medscape.com/viewarticle/946760

Mar 3rd, 2021 - Powerful things can happen when clinicians and researchers listen to patients ― that's the main takeaway message from a recent viral Twitter thread that was repeatedly described as "amazing," "incredible," "beautiful," and "inspiring" by readers, including many healthcare professionals. The 15-part tweet thread tells a story from nearly 20 years ago of what may be an unprecedented event in onco...

Task Force Tackles FDA Lamotrigine Cardiac Risk Warning
https://www.medscape.com/viewarticle/946270

Feb 22nd, 2021 - A joint task force of the American Epilepsy Society (AES) and International League Against Epilepsy (ILAE) has issued an advisory to address concerns arising from a Food and Drug Administration (FDA) warning of cardiac risk in patients taking the antiseizure drug lamotrigine. The task force is concerned that the FDA warning is based on data not yet widely available, and that its sweeping nature...

New Vaccine Sites in Urban California to Tackle COVID-19 Disparities
https://www.medscape.com/viewarticle/945262

Feb 5th, 2021 - LOS ANGELES (Reuters) - New vaccination centers are to open this month in the heart of two urban California communities especially hard hit by the coronavirus, as state and federal officials try to tackle racial and economic disparities hindering U.S. immunization efforts. Joint plans to launch the two sites on Feb. 16, at the Oakland-Alameda Coliseum in Oakland and the California State Univers...

Brazilian Researchers Tracking Reinfection by New Virus Variant
https://www.medscape.com/viewarticle/944748

Jan 26th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Just as Brazil surpassed 200,000 deaths from COVID-19 on January 7, news from Bahia added another layer of concern: A platform case report in a preprint detailed the first case of reinfection in that state, apparently caused by a new strain, one having the E484K mutation.  This new strain is now...

As Hospitals Cope With COVID-19 Surge, Cyber Threats Loom
https://www.medscape.com/viewarticle/942095

Dec 7th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. BURLINGTON, Vt. (AP) — By late morning on Oct. 28, staff at the University of Vermont Medical Center noticed the hospital's phone system wasn't working. Then the internet went down, and the Burlington-based center's technical infrastructure with it. Employees lost access to databases, digital he...

A Teenager With Fever Who Can’t Talk After Visiting Mexico
https://reference.medscape.com/viewarticle/891466

Oct 30th, 2020 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills using the following patient scenario and corresponding questions. If you have a case that you would like to suggest for a future Case Challenge, please ...

A Teenager With Fever Who Can’t Talk After Visiting Mexico
https://reference.medscape.com/viewarticle/891466_2

Oct 30th, 2020 - Physical Examination and Workup Upon physical examination, the patient's temperature is 98.2°F (36.8°C), blood pressure is 133/81 mm Hg, heart rate is 145 beats/min, respiratory rate is 36 breaths/min, oxygen saturation is 100% in room air, and weight is 71.65 lb (32nd percentile). She appears nontoxic. Her head and neck examination is unremarkable, other than tenderness of the bilateral tempor...

A Teenager With Fever Who Can’t Talk After Visiting Mexico
https://reference.medscape.com/viewarticle/891466_5

Oct 30th, 2020 - The patient was initially hospitalized for an unclear etiology of her symptoms and fever of unknown origin. Although many fevers of unknown origin are ultimately infectious in nature, accounting for more than 60% of pediatric cases, recognizing other potential causes is important.[4] These include oncologic, autoimmune, endocrine, inflammatory, or neurologic conditions, which are important to r...

VOYAGER PAD: Paclitaxel-Coated Devices Don't Increase Mortality
https://www.medscape.com/viewarticle/939512

Oct 21st, 2020 - No hint of increased mortality risk in association with the use of paclitaxel-coated devices for treatment of peripheral artery disease was detected in VOYAGER PAD, a multithousand-patient randomized trial with long-term follow-up and ascertainment of vital status in 99.6% of participants. Observers opined that the VOYAGER PAD findings effectively put to rest a nearly 2-year-old controversy ove...

These Secret Safety Panels Will Pick the COVID Vaccine Winners
https://www.medscape.com/viewarticle/938066

Sep 25th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.   Most Americans have never heard of Dr. Richard Whitley, an expert in pediatric infectious diseases at the University of Alabama-Birmingham. Yet as the coronavirus pandemic drags on and the public eagerly awaits a vaccine, he may well be among the most powerful people in the country. Whitley le...